Product
foselutoclax
1 clinical trial
9 indications
Indication
Diabetic Macular EdemaIndication
Retinal DiseaseIndication
Macular EdemaIndication
Diabetes MellitusIndication
Diabetic RetinopathyIndication
retinal degenerationIndication
Retinal DiseasesIndication
Eye DisordersIndication
EdemaClinical trial
A Phase 2b, Prospective, Multicenter, Randomized, Double-Masked, Active-Controlled Study to Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With Diabetic Macular EdemaStatus: Recruiting, Estimated PCD: 2025-03-01